156 related articles for article (PubMed ID: 20400197)
1. Mortality in patients with chronic and cleared hepatitis C viral infection: a nationwide cohort study.
Omland LH; Krarup H; Jepsen P; Georgsen J; Harritshøj LH; Riisom K; Jacobsen SE; Schouenborg P; Christensen PB; Sørensen HT; Obel N;
J Hepatol; 2010 Jul; 53(1):36-42. PubMed ID: 20400197
[TBL] [Abstract][Full Text] [Related]
2. Mortality in HIV-infected injection drug users with active vs cleared hepatitis C virus-infection: a population-based cohort study.
Omland LH; Jepsen P; Weis N; Christensen PB; Laursen AL; Nielsen H; Krarup H; Sørensen HT; Obel N
J Viral Hepat; 2010 Apr; 17(4):261-8. PubMed ID: 19709359
[TBL] [Abstract][Full Text] [Related]
3. The impact of HIV-1 co-infection on long-term mortality in patients with hepatitis C: a population-based cohort study.
Omland LH; Jepsen P; Skinhøj P; Jørgensen HL; Münster AM; Bangsborg J; Fenger M; Sørensen HT; Obel N
HIV Med; 2009 Feb; 10(2):65-71. PubMed ID: 19018878
[TBL] [Abstract][Full Text] [Related]
4. Mortality among patients with cleared hepatitis C virus infection compared to the general population: a Danish nationwide cohort study.
Omland LH; Christensen PB; Krarup H; Jepsen P; Weis N; Sørensen HT; Obel N;
PLoS One; 2011; 6(7):e22476. PubMed ID: 21789259
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up among Danish transfusion recipients identified in the national hepatitis C lookback.
Just SA; Grau K; Georgsen J; Weis N; Cowan S; Groenbaek K; Krarup H; Christensen PB;
Transfusion; 2012 Mar; 52(3):582-8. PubMed ID: 21883266
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: long-term predictors from a community-based cohort study.
Lee MH; Yang HI; Lu SN; Jen CL; Yeh SH; Liu CJ; Chen PJ; You SL; Wang LY; Chen WJ; Chen CJ
J Clin Oncol; 2010 Oct; 28(30):4587-93. PubMed ID: 20855826
[TBL] [Abstract][Full Text] [Related]
7. Natural history of acute symptomatic hepatitis type C.
Wawrzynowicz-Syczewska M; Kubicka J; Lewandowski Z; Boroń-Kaczmarska A; Radkowski M
Infection; 2004 Jun; 32(3):138-43. PubMed ID: 15188072
[TBL] [Abstract][Full Text] [Related]
8. All-cause and liver-related mortality in hepatitis C infected drug users followed for 33 years: a controlled study.
Kielland KB; Skaug K; Amundsen EJ; Dalgard O
J Hepatol; 2013 Jan; 58(1):31-7. PubMed ID: 22960427
[TBL] [Abstract][Full Text] [Related]
9. High rate of spontaneous clearance of acute hepatitis C virus genotype 3 infection.
Lehmann M; Meyer MF; Monazahian M; Tillmann HL; Manns MP; Wedemeyer H
J Med Virol; 2004 Jul; 73(3):387-91. PubMed ID: 15170633
[TBL] [Abstract][Full Text] [Related]
10. No impact of hepatitis C virus infection on mortality among drug users during the first decade after seroconversion.
Grady B; van den Berg C; van der Helm J; Schinkel J; Coutinho R; Krol A; Prins M
Clin Gastroenterol Hepatol; 2011 Sep; 9(9):786-792.e1. PubMed ID: 21699803
[TBL] [Abstract][Full Text] [Related]
11. Mortality in siblings of patients coinfected with HIV and hepatitis C virus.
Hansen AB; Gerstoft J; Kronborg G; Pedersen C; Sorensen HT; Obel N
J Infect Dis; 2007 Jan; 195(2):230-5. PubMed ID: 17191168
[TBL] [Abstract][Full Text] [Related]
12. The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.
Di Martino V; Rufat P; Boyer N; Renard P; Degos F; Martinot-Peignoux M; Matheron S; Le Moing V; Vachon F; Degott C; Valla D; Marcellin P
Hepatology; 2001 Dec; 34(6):1193-9. PubMed ID: 11732009
[TBL] [Abstract][Full Text] [Related]
13. Fracture risk in hepatitis C virus infected persons: results from the DANVIR cohort study.
Hansen AB; Omland LH; Krarup H; Obel N;
J Hepatol; 2014 Jul; 61(1):15-21. PubMed ID: 24650694
[TBL] [Abstract][Full Text] [Related]
14. Assessment of long-term outcomes of community-acquired hepatitis C infection in a cohort with sera stored from 1971 to 1975.
Rodger AJ; Roberts S; Lanigan A; Bowden S; Brown T; Crofts N
Hepatology; 2000 Sep; 32(3):582-7. PubMed ID: 10960453
[TBL] [Abstract][Full Text] [Related]
15. Impact of hepatitis C virus infection on all-cause and liver-related mortality in a large community-based cohort of inner city residents.
Grebely J; Raffa JD; Lai C; Kerr T; Fischer B; Krajden M; Dore GJ; Tyndall MW
J Viral Hepat; 2011 Jan; 18(1):32-41. PubMed ID: 20196806
[TBL] [Abstract][Full Text] [Related]
16. Predictors of antiviral treatment initiation in hepatitis C virus-infected patients: a Danish cohort study.
Hansen N; Obel N; Christensen PB; Krarup H; Laursen AL; Clausen MR; Lunding S; Møller A; Schlichting P; Kromann-Andersen H; Bukh J; Weis N;
J Viral Hepat; 2009 Sep; 16(9):659-65. PubMed ID: 19486467
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis A virus infection suppresses hepatitis C virus replication and may lead to clearance of HCV.
Deterding K; Tegtmeyer B; Cornberg M; Hadem J; Potthoff A; Böker KH; Tillmann HL; Manns MP; Wedemeyer H
J Hepatol; 2006 Dec; 45(6):770-8. PubMed ID: 17034895
[TBL] [Abstract][Full Text] [Related]
18. Trends in mortality after diagnosis of hepatitis B or C infection: 1992-2006.
Walter SR; Thein HH; Amin J; Gidding HF; Ward K; Law MG; George J; Dore GJ
J Hepatol; 2011 May; 54(5):879-86. PubMed ID: 21145812
[TBL] [Abstract][Full Text] [Related]
19. Higher clearance of hepatitis C virus infection in females compared with males.
Bakr I; Rekacewicz C; El Hosseiny M; Ismail S; El Daly M; El-Kafrawy S; Esmat G; Hamid MA; Mohamed MK; Fontanet A
Gut; 2006 Aug; 55(8):1183-7. PubMed ID: 16434426
[TBL] [Abstract][Full Text] [Related]
20. Little evidence that hepatitis C virus leads to a higher risk of mortality in the absence of cirrhosis and excess alcohol intake: the Swiss Hepatitis C Cohort Study.
Prasad L; Spicher VM; Negro F; Rickenbach M; Zwahlen M;
J Viral Hepat; 2009 Sep; 16(9):644-9. PubMed ID: 19243494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
